产品详情 |
Edit |   |
Antigenic Specificity | B7-2/CD86 |
Clone | GL1 |
Host Species | Rat |
Reactive Species | human, mouse |
Isotype | IgG2a kappa |
Format | Protein G purified, no preservative |
Size | 0.025 mg |
Concentration | 0.5 mg/ml |
Applications | Flow Cytometry, Neutralization, Knockout Validated. Measured by its ability to neutralize B7-2/CD86-induced IL-2 secretion in the Jurkat human acute T cell leukemia cell line. The Neutralization Dose (ND50) is typically 0.05-0.25 ug/mL in the presence of 0.5 ug/mL Recombinant Mouse B7-2/CD86 Fc Chimera and 10 ug/mL PHA. (Linsley, P. et al. (1990) Proc. Natl. Acad. Sci. 87:5031). |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | The B7-2/CD86 Antibody (GL1) from Novus Biologicals is a rat monoclonal antibody to B7-2/CD86. This antibody reacts with human, mouse. The B7-2/CD86 Antibody (GL1) has been validated for the following applications: Flow Cytometry, Neutralization, Knockout Validated. |
Immunogen | LPS-activated mouse B cells |
Other Names | Activation B7-2 antigen, B70, B7-2, B7-2 antigen, B-lymphocyte activation antigen B7-2, BU63, CD28 antigen ligand 2, CD28LG2B7-2 antigen), CD86 antigen, CD86 molecule, CTLA-4 counter-receptor B7.2, FUN-1, LAB72, MGC34413, T-lymphocyte activation antigen CD86 |
Gene, Accession # | CD86, Gene ID: 942 |
Catalog # | NBP2-30148SS |
Price | |
Order / More Info | B7-2/CD86 Antibody from NOVUS BIOLOGICALS, LLC |
Product Specific References | PubMed: 11877283 |
产品资料 |
|
|